AAAAAA
Results: 1-25/27
Authors:
GERAK LR
BRANDT MR
FRANCE CP
Citation: Lr. Gerak et al., STUDIES ON BENZODIAZEPINES AND OPIOIDS ADMINISTERED ALONE AND IN COMBINATION IN RHESUS-MONKEYS - VENTILATION AND DRUG DISCRIMINATION, Psychopharmacology, 137(2), 1998, pp. 164-174
Authors:
GAUTHIER CA
GERAK LR
BAGLEY JR
BROCKUNIER LL
FRANCE CP
Citation: Ca. Gauthier et al., THE RATE-DECREASING EFFECTS OF FENTANYL DERIVATIVES IN PIGEONS BEFORE, DURING AND AFTER CHRONIC MORPHINE TREATMENT, Psychopharmacology, 137(1), 1998, pp. 67-73
Authors:
GERAK LR
ESTUPINAN LE
FRANCE CP
Citation: Lr. Gerak et al., VENTILATORY EFFECTS OF NEGATIVE GABA(A) MODULATORS IN RHESUS-MONKEYS, Pharmacology, biochemistry and behavior, 61(4), 1998, pp. 375-380
Authors:
LELAS S
GERAK LR
LANDERS LK
BRANDT MR
BAGLEY JR
BROCKUNIER LL
FRANCE CP
Citation: S. Lelas et al., PHARMACOLOGICAL PROFILE OF A DEUTERIUM-SUBSTITUTED MIRFENTANIL DERIVATIVE, OHM10579, IN RHESUS-MONKEYS, Pharmacology, biochemistry and behavior, 60(3), 1998, pp. 665-675
Authors:
FRANCE CP
AHN SC
BROCKUNIER LL
BAGLEY JR
BRANDT MR
WINSAUER PJ
MOERSCHBAECHER JM
Citation: Cp. France et al., BEHAVIORAL-EFFECTS AND BINDING AFFINITIES OF THE FENTANYL DERIVATIVE OHM3507, Pharmacology, biochemistry and behavior, 59(2), 1998, pp. 295-303
Authors:
GERAK LR
FRANCE CP
Citation: Lr. Gerak et Cp. France, REPEATED ADMINISTRATION OF FLUMAZENIL DOES NOT ALTER ITS POTENCY IN MODIFYING SCHEDULE-CONTROLLED BEHAVIOR IN CHLORDIAZEPOXIDE-TREATED RHESUS-MONKEYS, Psychopharmacology, 131(1), 1997, pp. 64-70
Authors:
FRANCE CP
GERAK LR
Citation: Cp. France et Lr. Gerak, DISCRIMINATIVE STIMULUS EFFECTS OF FLUMAZENIL IN RHESUS-MONKEYS TREATED CHRONICALLY WITH CHLORDIAZEPOXIDE, Pharmacology, biochemistry and behavior, 56(3), 1997, pp. 447-455
Authors:
BRANDT MR
CABANSAG SR
FRANCE CP
Citation: Mr. Brandt et al., DISCRIMINATIVE STIMULUS EFFECTS OF L-ALPHA-ACETYLMETHADOL (LAAM), BUPRENORPHINE AND METHADONE IN MORPHINE-TREATED RHESUS-MONKEYS, The Journal of pharmacology and experimental therapeutics, 282(2), 1997, pp. 574-584
Authors:
GERAK LR
FRANCE CP
Citation: Lr. Gerak et Cp. France, CHANGES IN SENSITIVITY TO THE RATE-DECREASING EFFECTS OF OPIOIDS IN PIGEONS TREATED ACUTELY OR CHRONICALLY WITH L-ALPHA-ACETYLMETHADOL, The Journal of pharmacology and experimental therapeutics, 281(2), 1997, pp. 799-809
Authors:
GERAK LR
FRANCE CP
Citation: Lr. Gerak et Cp. France, CHANGES IN SENSITIVITY TO THE RATE-DECREASING EFFECTS OF OPIOIDS IN PIGEONS TREATED ACUTELY OR CHRONICALLY WITH NALBUPHINE, Behavioural pharmacology, 7(5), 1996, pp. 437-447
Authors:
CARR DJJ
BROCKUNIER LL
SCOTT M
BAGLEY JR
FRANCE CP
Citation: Djj. Carr et al., MIRFENTANIL ANTAGONIZES MORPHINE-INDUCED SUPPRESSION OF SPLENIC NK ACTIVITY IN MICE, Immunopharmacology, 34(1), 1996, pp. 9-16
Authors:
BRANDT MR
FRANCE CP
Citation: Mr. Brandt et Cp. France, DISCRIMINATIVE STIMULUS EFFECTS OF ENADOLINE IN PIGEONS, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 960-967
Authors:
GERAK LR
FRANCE CP
Citation: Lr. Gerak et Cp. France, DISCRIMINATIVE STIMULUS EFFECTS OF NALBUPHINE IN RHESUS-MONKEYS, The Journal of pharmacology and experimental therapeutics, 276(2), 1996, pp. 523-531
Authors:
FRANCE CP
CARR DJJ
BROCKUNIER LL
BAGLEY JR
Citation: Cp. France et al., OHM3597 - A NOVEL FENTANYL DERIVATIVE WITH MORPHINE-LIKE BEHAVIORAL-EFFECTS IN RHESUS-MONKEYS, Drug development research, 35(1), 1995, pp. 49-58
Authors:
BUTELMAN ER
FRANCE CP
WOODS JH
Citation: Er. Butelman et al., AGONIST AND ANTAGONIST EFFECTS OF DYNORPHIN A-(1-13) IN A THERMAL ANTINOCICEPTION ASSAY IN RHESUS-MONKEYS, The Journal of pharmacology and experimental therapeutics, 275(1), 1995, pp. 374-380
Authors:
BAKER ML
BROCKUNIER LL
BAGLEY JR
FRANCE CP
CARR DJJ
Citation: Ml. Baker et al., FENTANYL-RELATED 4-HETEROANILIDO PIPERIDINE OHM3295 AUGMENTS SPLENIC NATURAL-KILLER ACTIVITY AND INDUCES ANALGESIA THROUGH OPIOID RECEPTOR PATHWAYS, The Journal of pharmacology and experimental therapeutics, 274(3), 1995, pp. 1285-1292
Authors:
FRANCE CP
GERAK LR
FLYNN D
WINGER GD
MEDZIHRADSKY F
BAGLEY JR
BROCKUNIER LL
WOODS JH
Citation: Cp. France et al., BEHAVIORAL-EFFECTS AND RECEPTOR-BINDING AFFINITIES OF FENTANYL DERIVATIVES IN RHESUS-MONKEYS, The Journal of pharmacology and experimental therapeutics, 274(1), 1995, pp. 17-28
Authors:
FRANCE CP
Citation: Cp. France, DISCRIMINATION AMONG MORPHINE, SALINE AND NALTREXONE IN RHESUS-MONKEYS RECEIVING MORPHINE SUBCHRONICALLY, Behavioural pharmacology, 5(1), 1994, pp. 15-20
Authors:
CARR DJJ
BAKER ML
HOLMES C
BROCKUNIER LL
BAGLEY JR
FRANCE CP
Citation: Djj. Carr et al., OHM3295 - A FENTANYL-RELATED 4-HETEROANILIDO PIPERIDINE WITH ANALGESIC EFFECTS BUT NOT SUPPRESSIVE EFFECTS ON SPLENIC NK ACTIVITY IN MICE, International journal of immunopharmacology, 16(10), 1994, pp. 835-844
Authors:
BUTELMAN ER
FRANCE CP
WOODS JH
Citation: Er. Butelman et al., INTERACTION OF IV DYNORPHIN A(1-13) WITH KAPPA-AGONIST AND MU-AGONISTIN A THERMAL ANTINOCICEPTION ASSAY IN RHESUS-MONKEYS, Regulatory peptides, 1994, pp. 190000087-190000088
Authors:
FRANCE CP
GERAK LR
WINGER G
WOODS JH
BROCKUNIER LL
BAGLEY JR
Citation: Cp. France et al., BEHAVIORAL-EFFECTS OF FENTANYL DERIVATIVES IN RHESUS-MONKEYS, Regulatory peptides, 1994, pp. 190000185-190000186
Authors:
GERAK LR
BUTELMAN ER
WOODS JH
FRANCE CP
Citation: Lr. Gerak et al., ANTINOCICEPTIVE AND RESPIRATORY EFFECTS OF NALBUPHINE IN RHESUS-MONKEYS, The Journal of pharmacology and experimental therapeutics, 271(2), 1994, pp. 993-999
Authors:
FRANCE CP
GERAK LR
Citation: Cp. France et Lr. Gerak, BEHAVIORAL-EFFECTS OF 6-METHYLENE NALTREXONE (NALMEFENE) IN RHESUS-MONKEYS, The Journal of pharmacology and experimental therapeutics, 270(3), 1994, pp. 992-999
Authors:
CARR DJJ
GERAK LR
FRANCE CP
Citation: Djj. Carr et al., NALTREXONE ANTAGONIZES THE ANALGESIC AND IMMUNOSUPPRESSIVE EFFECTS OFMORPHINE IN MICE, The Journal of pharmacology and experimental therapeutics, 269(2), 1994, pp. 693-698
Authors:
FRANCE CP
MEDZIHRADSKY F
WOODS JH
Citation: Cp. France et al., COMPARISON OF KAPPA-OPIOIDS IN RHESUS-MONKEYS - BEHAVIORAL-EFFECTS AND RECEPTOR-BINDING AFFINITIES, The Journal of pharmacology and experimental therapeutics, 268(1), 1994, pp. 47-58